Contact Us


For more information on specific business or products, please get in touch with us at

General Enquiries: neopharma@neopharma.com

Business Development / Partnerships: bd@neopharma.com

Neopharma

Plot A-1 89-95, Industrial City of
Abu Dhabi (ICAD), Mussafah,Abu Dhabi,
United Arab Emirates.
Tel:+971-025501000

Neopharma Inc.

Subsidiary of Neopharma

116 Village Blvd Suite 200 Forrestal Village,
Princeton, NJ, 08540, USA
Tel: +14257727407

Sauad Farmaceutica

Subsidiary of Neopharma

Rod GO 010 km 32, Sitio do
Sobradinho, Zona Rural, Bonfinopolis,
Goias, Brazil, CEP 75195-000.
Tel: +55 62 3334-1698

www.sauadfarmaceutica.com.br

Neopharma Russia

Subsidiary of Neopharma

Building 1, Office 207,
Street 65, Profsouznaya,
Moscow, Russia 117342

Omnicare Drugs India Pvt. Ltd.

Subsidiary of Neopharma

Office 401, Manjeera Trinity Corporate,
JNTU, Kukatpally, Hyderabad,
Telangana, India-500072
Tel: +914067818000

Neopharma Japan Co. Ltd

Subsidiary of Neopharma

Iidabashi Grand Bloom,
4th Floor, Fujimi 2-10-2 Chiyoda-ku,
Tokyo 102-0071
Tel: +0120-392-750

www.neopharmajp.co.jp

Pharmaline Inc

Subsidiary of Neopharma

Unit 5 2835 Argentia Road,
Mississauga On, Canada L5N 8G6
Tel: +19058123916

www.pharmalineinc.com

Reporting Adverse Events


Patient health and safety is of foremost concern for all our healthcare products. In order to continuously monitor and for the assessment of the benefit-risk ratio of our medicines, we encourage you all to report any adverse events that occurs due to the usage of our products.

You can report an adverse event in the following ways:

  • Contact your personal physician, who will then notify Neopharma
  • By using our phone, fax or email:

Toll Free Number: 80003110058
Fax: +971 43970941
Email: neopharma.pv@neopharma.com

  • In person/by post: Neopharma, Plot A-1 89-95, Industrial City of Abu Dhabi (ICAD), Mussafah, P.O. Box 72900, Abu Dhabi, United Arab Emirates
TOP